The Impact of KETO5 XOGenius Beverage on Markers of Physiological and Neurocognitive Health
Launched by THE UNIVERSITY OF TEXAS AT ARLINGTON · Mar 12, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a special drink called Keto5 XOGenius on health, particularly how it may help with brain function and conditions like heart disease and high blood pressure. The researchers want to see if drinking this beverage every day can lead to improvements in health markers such as weight, waist size, and overall body composition.
To participate in this study, you need to be between 18 and 50 years old and generally healthy. However, certain conditions may disqualify you, like having diabetes, food allergies, or currently taking medications for heart or metabolic issues. If you join the study, you may be asked to track your health over time while regularly consuming the Keto5 XOGenius drink. The trial is currently looking for participants, and your involvement could help researchers learn more about how diet affects our health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Men and women who are between the ages of 18-50
- Exclusion Criteria:
- • Individuals who have donated more than 550 ml of blood within the past 8 weeks will not have blood drawn from them in this protocol. However, if they remain interested in the study, and otherwise meet the inclusion criteria, then we may still opt to proceed with data collection.
- • Food allergies
- • Type I diabetes/Type II diabetes, and/or a history of hypoglycemia.
- • History of irritable bowel syndrome or inflammatory bowel disease.
- • Currently taking any medications that are designed to treat a cardiovascular or metabolic condition
- • Pregnant women
- • Breast feeding women
- • Allergy to spandex/lycra/latex
- • Anemia
- • Use of prescription stimulants
About The University Of Texas At Arlington
The University of Texas at Arlington (UTA) is a leading academic institution dedicated to advancing research and innovation across various fields, including health sciences. With a strong commitment to improving public health and clinical outcomes, UTA actively sponsors clinical trials that aim to explore novel therapeutics, enhance patient care, and address pressing health challenges. The university's interdisciplinary approach fosters collaboration among researchers, healthcare professionals, and community stakeholders, ensuring that trials are conducted with rigor and integrity. UTA's state-of-the-art facilities and access to diverse patient populations enable the effective execution of clinical research, contributing to the advancement of medical knowledge and practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Arlington, Texas, United States
Patients applied
Trial Officials
Robert M Brothers, PhD
Principal Investigator
University of Texas at Arlington
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported